Kerendia is a medicine used to treat chronic kidney disease in adults with type 2 diabetes. It is used for patients with moderate or severe kidney damage who pass albumin (a type of protein) in their urine. Kerendia contains the active substance finerenone.
Therapeutic Indication
### Therapeutic indication Kerendia is indicated for the treatment of chronic kidney disease (stage 3 and 4 with albuminuria) associated with type 2 diabetes in adults.
Therapeutic Area (MeSH)
ATC Code
C09
ATC Item
作用于肾素-血管紧张素系统的药物
Pharmacotherapeutic Group
Agents acting on the renin-angiotensin system
Active Substance (Summary)
INN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| Finerenone | N/A | 非奈利酮 |
EMA Name
Kerendia
Medicine Name
Kerendia
Aliases
N/ANo risk management plan link.
